A statistically significant increase was observed in both T2D patient groups (Group A: T2D with VED and group B: T2D without VED) compared to the controls (group C) on the rate of fasting glucose, HbA1c, insulin, HOMA IR, total cholesterol and LDL-cholesterol plasmatic levels. The gene discussed is INS; the disease is type 2 diabetes mellitus.